JUN 10, 2020 8:22 PM PDT

A Highly Targeted Cancer Therapeutic

WRITTEN BY: Nouran Amin

A study led by researchers at USC School of Pharmacy discusses a way to engineer drugs that highly target malignant tissues without affecting surrounding healthy tissues. These engineered compounds are known as ‘antibody-drug conjugates’ or ADCs that lead the way to better therapeutics for diverse types of cancer.

Learn more:

"Using our approach, homogenous ADCs could be made through a single-step reaction in less than two hours, much faster and more efficiently than conventional approaches," says the study's Principal Investigator, Yong (Tiger) Zhang, Assistant Professor of Pharmacology and Pharmaceutical Sciences at the USC School of Pharmacy.

As of now, only eight ADC drugs have been approved by the FDA after countless clinical trials evaluating their efficacy and safety in treating leukemia, breast cancer, lung cancer and so much more. The findings were published in Science Advances and describes how ADCs include an antibody that hunts for cancer and that antibody has a chemical linker that is “linking it” to a drug eventually uniting them and eradicating the cancer. This is precisely what makes ADC such an engineered targeted approach.

"Our technology features a designer 'linker' component exclusively recognized by a human enzyme that can rapidly catalyze the conjugation of drug molecules to the antibodies at a defined position," he says. "In addition to its fast rate and high efficiency, our ADC technology offers a new type of linker for connecting the drugs to antibodies. This designer linker ensures stable attachment of the drug and rapid release of the drugs into target cells, making the generated ADCs safer and more efficacious."

Source:  Science Daily

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
MAY 06, 2021
Drug Discovery & Development
Tweaked Version of Ketamine Could Solve the Opioid Crisis
MAY 06, 2021
Tweaked Version of Ketamine Could Solve the Opioid Crisis
Medications that manage post-operative pain are some of the main entry points to opioid addiction and overdose in the US ...
MAY 17, 2021
Immunology
Understanding Inflammation: A Faster, Easier Way to Detect Cytokines in Cells
MAY 17, 2021
Understanding Inflammation: A Faster, Easier Way to Detect Cytokines in Cells
Inflammation, a process that was meant to defend our body from infection, has been found to contribute to a wide range o ...
MAY 13, 2021
Health & Medicine
New Peptide Allows Cannabis to Fight Pain With Fewer Side Effects
MAY 13, 2021
New Peptide Allows Cannabis to Fight Pain With Fewer Side Effects
THC-rich cannabis is well known to bring relief for some chronic pain sufferers. But the downside, off putting for many ...
MAY 14, 2021
Health & Medicine
A National Standard THC Dose for Researchers is Here
MAY 14, 2021
A National Standard THC Dose for Researchers is Here
    Whatever your stance on cannabis, almost  everyone would agree that more, better quality, research sh ...
MAY 28, 2021
Cell & Molecular Biology
Some Animals Can Breathe Through Their Whats?
MAY 28, 2021
Some Animals Can Breathe Through Their Whats?
There are some aquatic animals like sea cucumbers and some types of catfish that can survive in environments with limite ...
JUN 10, 2021
Cell & Molecular Biology
Does Lithium Prevent Colon Cancer?
JUN 10, 2021
Does Lithium Prevent Colon Cancer?
Researchers found that a drug used in the treatment of mental illness can promote the fitness of healthy gut stem cells, ...
Loading Comments...